Moreover, Payne et al. (2023) further demonstrated the versatility of TR-FRET by using it to quantify endogenous BRD4 protein levels in cancer cells, enabling rapid validation of small-molecule BRD4 degraders [88]. Here, BRD4 is linked to cancer.